Tommy Ivanics
Overview
Explore the profile of Tommy Ivanics including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
590
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patel M, Shankar S, Tejedor M, Barbas A, Kim J, Mao S, et al.
Liver Transpl
. 2025 Mar;
PMID: 40062745
The 2024 Annual Congress of the International Liver Transplantation Society (ILTS) was from May 1-4th in Houston, Texas, USA, under the theme "Liver Disease and Transplantation: Breaking Barriers and Exploring...
2.
Gravely A, Claasen M, Ivanics T, Winter E, Peralta P, Selzner M, et al.
Clin Transplant
. 2025 Jan;
39(2):e70086.
PMID: 39869426
Background: Low post-operative day (POD) 1 Factor V has been retrospectively associated with graft loss after liver transplantation when stratified by a cutoff of 0.36 U/mL. We aimed to validate...
3.
Choi W, Ivanics T, Rajendran L, Li Z, Gavira F, Jones O, et al.
Surgery
. 2024 Nov;
:108917.
PMID: 39609218
Background: Solitary hepatocellular carcinoma measuring ≤3 cm represents approximately 30% of hepatocellular carcinoma cases, yet treatment guidelines lack robust evidence. This study compares oncologic outcomes after ablation, liver resection, and...
4.
Ciria R, Ivanics T, Aliseda D, Claasen M, Alconchel F, Gaviria F, et al.
Hepatology
. 2024 Oct;
PMID: 39465987
Background And Aims: Liver transplant (LT) for transplant oncology (TO) indications is being slowly adopted worldwide and has been recommended to be incorporated cautiously due to concerns about mid-long-term survival...
5.
Magyar C, Li Z, Aceituno L, Claasen M, Ivanics T, Choi W, et al.
Am J Transplant
. 2024 Aug;
25(2):406-416.
PMID: 39163907
Living donor liver transplantation (LDLT) is a curative treatment for various liver diseases, reducing waitlist times and associated mortality. We aimed to assess the overall survival (OS), identify predictors for...
6.
Li Z, Jones O, Magyar C, Claasen M, Ivanics T, Choi W, et al.
Ann Surg
. 2024 Jul;
PMID: 39041223
Objective: Assess the impact of having a living donor on waitlist outcomes and overall survival through an intention-to-treat analysis. Background: Living-donor liver transplantation (LDLT) offers an alternative to deceased donation...
7.
Berardi G, Cucchetti A, Sposito C, Ratti F, Nebbia M, DSouza D, et al.
JHEP Rep
. 2024 Jul;
6(7):101075.
PMID: 38961853
Background & Aims: Metabolic syndrome (MS) is a growing epidemic and a risk factor for the development of hepatocellular carcinoma (HCC). This study investigated the long-term outcomes of liver resection...
8.
Jones O, Claasen M, Ivanics T, Choi W, Gavaria F, Rajendran L, et al.
Liver Transpl
. 2024 Apr;
30(8):785-795.
PMID: 38619393
Living donor liver transplantation (LDLT) offers the opportunity to decrease waitlist time and mortality for patients with autoimmune liver disease (AILD), autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis....
9.
Wang B, Chen A, Prasadh J, Desai D, Shubin A, Raschzok N, et al.
World J Surg
. 2024 Feb;
48(2):437-445.
PMID: 38310313
Background: Pre-transplant deceased donor liver biopsy may impact decision making; however, interpretation of the results remains variable and depends on accepting center practice patterns. Methods: In this cohort study, adult...
10.
Briere R, Emond M, Benhamed A, Blanchard P, Golbon B, Shellenberger J, et al.
Can J Surg
. 2024 Jan;
66(6 Suppl 1):S54-S136.
PMID: 38173057
No abstract available.